Immuron (IMRN) Times Interest Earned (2016 - 2024)
Immuron (IMRN) posted quarterly Times Interest Earned of -$631.4 million for Q4 2024, down 125243619.8% year-on-year from N/an in Q1 2024, and down 125243619.8% on a QoQ basis from $504.12 in Q4 2023.
Immuron (IMRN) Times Interest Earned (2016 - 2024) Analysis & Trends
Immuron (IMRN) has reported Times Interest Earned for 9 consecutive years, with -$631.4 million the latest figure, recorded in Q4 2024.
- Quarterly Times Interest Earned fell 125243619.8% year-over-year to -$631.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$631.4 million (down 13926.57% YoY) and the FY2025 annual result came in at -$731.63, up 4.45% from the prior year.
- Times Interest Earned declined to -$631.4 million in Q4 2024 per IMRN's latest filing, from $504.12 in the prior quarter.
- Over the last five years, Times Interest Earned for IMRN reached as high as $216.7 million in Q4 2021 and fell as low as -$631.4 million in Q4 2024.
- A 5-year average of -$69.1 million and a median of $43.16 in 2020 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned jumped 10388338562.38% — and 2024, when it slumped 125243619.8%.
- Year by year, Times Interest Earned stood at $2.09 in 2020, then soared by 10388338562.38% to $216.7 million in 2021, then sank by 100.0% to $84.23 in 2022, then jumped by 498.53% to $504.12 in 2023, then sank by 125243619.8% to -$631.4 million in 2024.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$631.4 million, $504.12, and -$1100.3 for Q4 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -631.38 Mn |
| Dec 31, 2023 | 504.12 |
| Jun 30, 2023 | -1,100.27 |
| Dec 31, 2022 | 84.23 |
| Dec 31, 2021 | 216.73 Mn |
| Dec 31, 2020 | 2.09 |
| Dec 31, 2019 | 741,007.76 |
| Dec 31, 2018 | 40,562.51 |
| Dec 31, 2017 | -979.19 |
| Dec 31, 2016 | 87.93 |
| Jun 30, 2016 | -20.12 |